Catheter Precision (VTAK) Net Income towards Common Stockholders (2017 - 2025)
Historic Net Income towards Common Stockholders for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to -$2.2 million.
- Catheter Precision's Net Income towards Common Stockholders rose 4689.32% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.4 million, marking a year-over-year decrease of 10863.57%. This contributed to the annual value of -$21.8 million for FY2024, which is 6945.44% up from last year.
- According to the latest figures from Q3 2025, Catheter Precision's Net Income towards Common Stockholders is -$2.2 million, which was up 4689.32% from -$7.4 million recorded in Q2 2025.
- Catheter Precision's Net Income towards Common Stockholders' 5-year high stood at $3.1 million during Q3 2021, with a 5-year trough of -$67.2 million in Q1 2023.
- Moreover, its 5-year median value for Net Income towards Common Stockholders was -$4.1 million (2024), whereas its average is -$7.3 million.
- Per our database at Business Quant, Catheter Precision's Net Income towards Common Stockholders soared by 126666.67% in 2021 and then plummeted by 151225.71% in 2024.
- Over the past 5 years, Catheter Precision's Net Income towards Common Stockholders (Quarter) stood at $3.1 million in 2021, then crashed by 364.9% to -$8.2 million in 2022, then soared by 91.8% to -$669000.0 in 2023, then crashed by 1512.26% to -$10.8 million in 2024, then surged by 79.71% to -$2.2 million in 2025.
- Its Net Income towards Common Stockholders stands at -$2.2 million for Q3 2025, versus -$7.4 million for Q2 2025 and -$4.0 million for Q1 2025.